Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Autocrine IL-21 Stimulation Is Involved in the Maintenance of Constitutive STAT3 Activation in Sézary Syndrome
Leslie van der Fits, Jacoba J. Out‐Luiting, M.A. van Leeuwen, et al.
Journal of Investigative Dermatology (2011) Vol. 132, Iss. 2, pp. 440-447
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Deregulation in STAT signaling is important for cutaneous T-cell lymphoma (CTCL) pathogenesis and cancer progression
Elena Netchiporouk, Ivan V. Litvinov, Linda Moreau, et al.
Cell Cycle (2014) Vol. 13, Iss. 21, pp. 3331-3335
Open Access | Times Cited: 118
Staphylococcal enterotoxin A (SEA) stimulates STAT3 activation and IL-17 expression in cutaneous T-cell lymphoma
Andreas Willerslev-Olsen, Thorbjørn Krejsgaard, Lise M. Lindahl, et al.
Blood (2016) Vol. 127, Iss. 10, pp. 1287-1296
Open Access | Times Cited: 99
Analysis of STAT4 expression in cutaneous T-cell lymphoma (CTCL) patients and patient-derived cell lines
Ivan V. Litvinov, Brendan Cordeiro, Simon Fredholm, et al.
Cell Cycle (2014) Vol. 13, Iss. 18, pp. 2975-2982
Open Access | Times Cited: 70
New Therapies and Immunological Findings in Cutaneous T-Cell Lymphoma
Kazuyasu Fujii
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 68
A three‐signal model of T‐cell lymphoma pathogenesis
Ryan A. Wilcox
American Journal of Hematology (2015) Vol. 91, Iss. 1, pp. 113-122
Open Access | Times Cited: 67
CD4 T-cell cytokines synergize to induce proliferation of malignant and nonmalignant innate intraepithelial lymphocytes
Yvonne Kooy–Winkelaar, Dagmar Bouwer, George M. C. Janssen, et al.
Proceedings of the National Academy of Sciences (2017) Vol. 114, Iss. 6
Open Access | Times Cited: 53
Novel insights into the pathogenesis of T-cell lymphomas
John S. Van Arnam, Megan S. Lim, Kojo S.J. Elenitoba‐Johnson
Blood (2018) Vol. 131, Iss. 21, pp. 2320-2330
Open Access | Times Cited: 53
Molecular pathogenesis of Cutaneous T cell Lymphoma: Role of chemokines, cytokines, and dysregulated signaling pathways
Kalyani Patil, Shilpa Kuttikrishnan, Abdul Quaiyoom Khan, et al.
Seminars in Cancer Biology (2021) Vol. 86, pp. 382-399
Open Access | Times Cited: 40
Romidepsin and Afatinib Abrogate Jak–Signal Transducer and Activator of Transcription Signaling and Elicit Synergistic Antitumor Effects in Cutaneous T-Cell Lymphoma
Bobby B. Shih, Cindy Ma, José R. Cortés, et al.
Journal of Investigative Dermatology (2024) Vol. 144, Iss. 7, pp. 1579-1589.e8
Open Access | Times Cited: 4
Phenotypical Markers, Molecular Mutations, and Immune Microenvironment as Targets for New Treatments in Patients with Mycosis Fungoides and/or Sézary Syndrome
Pietro Quaglino, Paolo Fava, Alessandro Pileri, et al.
Journal of Investigative Dermatology (2020) Vol. 141, Iss. 3, pp. 484-495
Open Access | Times Cited: 34
Molecular and Genomic Landscape of Peripheral T-Cell Lymphoma
Javeed Iqbal, Catalina Amador, Timothy W. McKeithan, et al.
Cancer treatment and research (2018), pp. 31-68
Closed Access | Times Cited: 31
Novel therapies for cutaneous T-cell lymphoma: what does the future hold?
Emmanuella Guenova, Wolfram Hoetzenecker, Sima Rozati, et al.
Expert Opinion on Investigational Drugs (2014) Vol. 23, Iss. 4, pp. 457-467
Closed Access | Times Cited: 30
A new molecular paradigm in mycosis fungoides and Sézary syndrome
Kojo S.J. Elenitoba‐Johnson, Ryan A. Wilcox
Seminars in Diagnostic Pathology (2016) Vol. 34, Iss. 1, pp. 15-21
Closed Access | Times Cited: 29
Sézary syndrome: old enigmas, new targets
Jan P. Nicolay, Moritz Felcht, Kai Schledzewski, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2016) Vol. 14, Iss. 3, pp. 256-264
Open Access | Times Cited: 28
STAT3 Dysregulation in Mature T and NK Cell Lymphomas
Angelina Seffens, Alberto Herrera, Cosmin Tegla, et al.
Cancers (2019) Vol. 11, Iss. 11, pp. 1711-1711
Open Access | Times Cited: 28
Effect of IL-21 on the Balance of Th17 Cells/Treg Cells in the Pathogenesis of Graves’ Disease
Yan Tan, Wei Chen, Chun Liu, et al.
Endocrine Research (2019) Vol. 44, Iss. 4, pp. 138-147
Closed Access | Times Cited: 26
Exploring the IL-21–STAT3 Axis as Therapeutic Target for Sézary Syndrome
Leslie van der Fits, Jacoba J. Out‐Luiting, Cornelis P. Tensen, et al.
Journal of Investigative Dermatology (2014) Vol. 134, Iss. 10, pp. 2639-2647
Open Access | Times Cited: 27
New perspectives on the ligands and function of the killer cell immunoglobulin-like receptor KIR3DL2 in health and disease
Jacqueline Shaw, Simon Kollnberger
Frontiers in Immunology (2012) Vol. 3
Open Access | Times Cited: 25
Recent advances in primary cutaneous T-cell lymphoma
Jennifer DeSimone, Pooja Sodha, Desislava Ignatova, et al.
Current Opinion in Oncology (2015) Vol. 27, Iss. 2, pp. 128-133
Open Access | Times Cited: 24
A novel mouse model for Sézary Syndrome using xenotransplantation of Sézary cells into immunodeficient RAG2−/− γc−/− mice
Leslie van der Fits, Heggert Rebel, Jacoba J. Out‐Luiting, et al.
Experimental Dermatology (2012) Vol. 21, Iss. 9, pp. 706-709
Closed Access | Times Cited: 19
Interleukin-6 as a therapy target in oral squamous carcinoma
Zoran Čulig
Expert Opinion on Therapeutic Targets (2012) Vol. 17, Iss. 1, pp. 53-59
Closed Access | Times Cited: 18
New insights of common gamma chain in hematological malignancies
Tae Sik Goh, Changwan Hong
Cytokine (2015) Vol. 89, pp. 179-184
Closed Access | Times Cited: 10
Cutaneous Lymphomas: Molecular Pathways Leading to New Drugs
Reinhard Dummer, Simone M. Goldinger, Antonio Cozzio, et al.
Journal of Investigative Dermatology (2011) Vol. 132, Iss. 3, pp. 517-525
Open Access | Times Cited: 11
miR-337 suppresses cutaneous T-cell lymphoma via the STAT3 pathway
Liang Xia, Linlin Wu, Hailong Xia, et al.
Cell Cycle (2019) Vol. 18, Iss. 14, pp. 1635-1645
Open Access | Times Cited: 9
Update on Epidemiology of Cutaneous T-Cell Lymphoma
Sara Samimi, Alain H. Rook, Ellen J. Kim
Current Dermatology Reports (2013) Vol. 2, Iss. 1, pp. 35-41
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top